Liothyronine
- Level
- Commodity
- Parent
- 51181600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51181602This classification denotes a generic primary tumor tnm finding with the molecular formula C15H12I3NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06LU7C9H1V, chemically known as 3,5,3-triiodothyronine but generally known as liothyronine, which bears US NIH Compound Identifier 861. European Medicines Agency schedules Liothyronine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08527MIG. The term LIOTHYRONINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). LIOTHYRONINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, LIOTHYRONINE remains the US FDA Preferred Term for this commodity. Liothyronine bears US NLM identifiers UMLS ID CL414313 and NCI Concept Code C907. SMILES: IC1CC(CC(N)C(=O)O)CC(I)C1OC1CC(I)C(O)CC1.
Same parent
Under 51181600 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.